Turnstone Biologics Corp Common Stock

Quarterly Financials

Values in thousands 2024-06-30 2024-03-31 2023-12-31
Revenue
$0
$0
$0
Gross Profit
-500
-509
-661
EBITDA
-21,559
-20,182
-18,182
EBIT
-22,057
-20,691
-18,843
Net Income
-21,304
-19,629
-16,450
Net Change In Cash
0
0
0
Free Cash Flow
-16,122
-17,604
-15,504
Cash
17,517
14,433
17,798
Basic Shares
23,037
23,011
11,562

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31
Revenue
$19,306
$73,300
$101,293
Gross Profit
16,506
71,100
99,281
EBITDA
-56,234
-28,493
35,713
EBIT
-59,032
-30,693
33,701
Net Income
-55,200
-30,834
33,269
Net Change In Cash
19,306
73,300
101,293
Free Cash Flow
-67,401
-76,232
-49,035
Cash
17,798
34,731
123,381
Basic Shares
11,562
22,188
22,188

Earnings Calls

Quarter EPS
2024-09-30
-$0.73
2024-06-30
-$0.92
2024-03-31
-$0.85
2023-12-31
-$0.73